Summary
To study the mechanism of action of thyroid hormones on bone, we examined the effects of immunosuppresive and nonimmunosuppressive cyclosporins, as well as of transforming growth factor β1 (TGFβ1), 17β-estradiol (E2), and dihydroxytestosterone (DHT) on thyroxine (T4)-and triiodothyronine (T3)-stimulated bone resorption in fetal rat limb bones. The immunosuppressive cyclosporins A (CsA) and G (CsG) inhibited thyroid hormone (T4+T3)-stimulated resorption and β-glucuronidase release into the culture medium, whereas the weak or nonimmunosuppressive cyclosporins D (CsD) and H (CsH) did not show this effect. Increasing the medium calcium concentration reduced the ability of T4 to stimulate 45Ca release, while not significantly affecting the response to CsA. TGFβ1 elicited a biphasic effect when administered together with T4. During the first 3 days of culture, TGFβ1 elicited a small, nonsignificant decrease in released 45Ca; during a subsequent 3 days of culture, it enhanced T4-stimulated bone resorption significantly. These effects differed from those of TGFβ1 on parathormone-stimulated resorption. E2 and DHT did not influence the action of T4 on bone tissue. These results suggest that the mechanism of action of thyroid hormones on bone may involve immune factors, as well.
Similar content being viewed by others
References
Krane SM (1971) Skeletal system, neuromuscular system, emotions and mentation. In: Ingbar SH, Werner SC (eds) Harper & Row, New York, pp 598–615
Allwerx J, Bouillon R (1986) Mineral and bone metabolism in thyroid disease: a review. Quart J Med 232:737–752
Michie W, Duncan T, Hamer-Hodges DW, Bewsher PD, Hems G, Showers JM, Pegg CAS, Hedley AJ (1971) Mechanism of hypocalcemia after thyroidectomy for thyrotoxicosis. Lancet 1:508–513
Fraser SA, Anderson JB, Smith DA, Wilson GM (1971) Osteoporosis and fractures following thyrotoxicosis. Lancet i:981–983
Krolner B, Jorgensen JV, Nielsen SP (1983) Spinal bone mineral content in myxoedema and thyrotoxicosis, effects of thyroid hormone(s) and antithyroid treatment. Clin Endocrinol 18:439–446
Toh SH, Claunch BC, Brown PH (1985) Effects of hyperthyroidism and its treatment on bone mineral content. Arch Int Med 145:883–886
Lakatos P, Hollo I, Horvath Cs (1986) Severe postmenopausal osteoporosis and thyroid hormones. Arch Int Med 146:1859
Kragstrup J, Melsen F, Mosekilde L (1981) Effects of thyroid hormone(s) on mean wall thickness of trabecular bone pockets. Metab Bone Dis Rel Res 3:181–185
Fallon MD, Perry HM III, Bergfeld M, Droke D, Teitelbaum SL, Avioli LV (1983) Exogenous hyperthyroidism with osteoporosis. Arch Int Med 143:442–445
Ross DS, Neer RM, Ridgway EC, Daniels GH (1987) Subclinical hyperthyroidism and reduced bone density as a possible result of prolonged suppression of the pituitary-thyroid axis with L-thyroxine. Am J Med 82:1167–1170
Taelman P, Kaufman JM, Janssens X, Vandecauter H, Vermeulen A (1990) Reduced forearm bone mineral content and biochemical evidence of increased bone turnover in women with euthyroid goitre treated with thyroid hormone. Clin Endocrinol 33:107–117
Lakatos P, Tarian G, Foldes J, Krasznai I, Hollo I (1987) The effect of thyroid treatment on bone mineral content in patients with hypothyroidism and euthyroid benign adenoma. In: Christiansen C, Johansen JS, Riis BJ (eds) Proc Intl Symp on Osteoporosis, Vol 1. Denmark, September 27–October 2, Osteopress Aps, Copenhagen, Denmark, pp 452–453
Mundy GR, Shapiro JL, Bandelin JG, Canalis EM, Raisz LG (1976) Direct stimulation of bone resorption by thyroid hormones. J Clin Invest 58:529–534
Mundy GR, Raisz LG (1979) Thyrotoxicosis and calcium metabolism. Miner Electrolyte Metab 2:285–292
Klaushofer K, Hoffmann O, Gleispach H, Leis H, Czerwenka E, Koller K, Peterlik M (1989) Bone-resorbing activity of thyroid hormones is related to prostaglandin production in cultured neonatal mouse calvaria. J Bone Miner Res 4:305–312
Hoffmann O, Klaushofer K, Koller K, Peterlik M, Mavreas T, Stern P (1986) Indomethacin inhibits thrombin-, but not thyroxin-stimulated resorption of fetal rat limb bones. Prostaglandins 31:601–607
Grossman CJ (1991) Immunoendocrinology. In: Greenspan FS (ed) Basic and clinical endocrinology. Appleton & Lange, Norwalk, CT/San Mateo, CA, pp 188–246
Fibbe WE, Claas FH, Van der Star-Dijkstra W, Schaafsma MR, Meyboom RH, Falkenburg JH (1986) Agranulocytosis induced by propylthiouracil: evidence of drug dependent antibody reacting with granulocytes, monocytes and hematopoietic progenitor cells. Br J Haematol 64:363–373
Burman KD, Baker JR Jr (1985) Immune mechanisms in Graves' disease. End Rev 6:183–232
Mundy GR (1990) Immune system and bone remodeling. TEM July/August 307–311
Stewart PJ, Green OC, Stern PH (1986) Cyclosporine A inhibits calcemic hormone-induced bone resorption in vitro. J Bone Miner Res 1:285–291
Stewart PJ, Stern PH (1989) Cyclosporines: correlation of immunosuppressive activity and inhibition of bone resorption. Calcif Tissue Int 45:222–226
Pfeilschifter JP, Seyedin S, Mundy GR (1988) Transforming growth factor β inhibits bone resorption in fetal rat long bone cultures. J Clin Invest 82:680–685
Tashijan AH Jr, Voelkel EF, Lazzaro M, Singer FR, Roberts AB, Derynck R, Winkler ME, Levine L (1985) α and β human transforming growth factors stimulate prostaglandin production and bone resorption in cultured mouse calvaria. Proc Natl Acad Sci USA 82:4535–4538
Stern PH (1969) Inhibition by steroids of parathyroid hormone-induced 45Ca release from embryonic rat bone in vitro. J Pharmacol Exp Ther 168:211–217
Stern PH, Krieger NS (1983) Comparison of fetal rat limb bones and neonatal mouse calvaria: effects of parathyroid hormone and 1,25-(OH)2D3. Calcif Tissue Int 35:172–176
Movsowitz C, Epstein S, Fallon M, Ismail F, Thomas S (1988) Cyclosporin A in vivo produces severe osteopenia in the rat: effect of dose and duration of administration. Endocrinology 123:2571–2577
Schlosberg M, Movsowitz C, Epstein S, Ismail F, Fallon M, Thomas S (1989) The effect of cyclosporin A administration and its withdrawal on bone mineral metabolism in the rat. Endocrinology 124:2179–2184
Loertscher R, Thiel G, Hardner F, Brunner FP (1983) Persistent elevation of alkaline phosphatase in cyclosporine-treated renal transplant patients. Transplantation 36:115–117
Briner V, Brunner FP, Landmann J, Ritz E, Dambacher MA, Thiel G (1987) Raised bone alkaline phosphatase levels in patients (PTS) on cyclosporine A (CsA): bone disease or repair. Kidney Int 32:431
Aubia J, Masramon J, Serrano S, Lloveras J, Marinoso L (1988) Bone histology in renal transplant patients receiving cyclosporin. Lancet 1:1048
Rich GM, Mudge G, LeBoff MS (1990) Cyclosporin A-associated osteoporosis in cardiac transplant patients. J Bone Miner Res 5(S2):439
Epstein S, Stein B, Halloran B, Takizawa M (1990) Cyclosporin A increases endogenous production of 1,25(OH)2D (#1 and 2). J Bone Miner Res 5:(S):493–494
Taylor CM, Caverzasio J, Jung A, Trechsel U, Fleish H, Bonjour JP (1983) Unilateral nephrectomy and 1,25-dihydroxyvitamin D3. Kidney Int 24:37–42
Almond JR, Bales CW, Lobaugh B, Klotman PE, Drezner MK (1989) Regulation of renal 25-hydroxyvitamin D-1-hydroxylase activity in the mouse after uninephrectomy. Endocrinology 124:2118–2121
Langman CB, Ford KK, Pachman LM, Glorieux F (1990) Vitamin D metabolism in rats with adjuvant-induced arthritis. J Bone Miner Res 5:905–912
del Pozo E, Graeber M, Elford P, Payne T (1990) Regression of bone and cartilage loss in adjuvant arthritic rats after treatment with cyclosporin A. Arthritis Rheum 33:247–252
Gelfand EW, Cheung RK, Mills GB (1987) The cyclosporins inhibit lymphocyte activation at more than one site. J Immunol 138:1115–1120
Nicchitta C, Kamoun M, Williamson JR (1985) Cyclosporine augments receptor-mediated cellular Ca2+ fluxes in isolated hepatocytes. J Biol Chem 260:13613–13618
Draznin B, Metz SA, Sussman KE, Leitner JW (1988) Cyclosporine-induced inhibition of insulin release. Possible role of voltage-dependent calcium transport channels. Biochem Pharmacol 37:3941–3945
Colombani PM, Robb A, Hess AD (1985) Cyclosporin A binding to calmodulin: a possible site of action on T lymphocytes. Science 228:337–339
LeGrue SJ, Turner R, Weisbrodt N, Dedman JR (1986) Does the binding of cyclosporine to calmodulin result in immunosuppression? Science 234:68–71
Szamel M, Berger P, Resch K (1984) Cyclosporin A inhibits lymphocyte activation by interfering with the early activation of plasma phospholipid metabolism. J Immunol 167:864–870
Szamel M, Martin M, Resch ZK (1985) Inhibition of lymphocyte activation by cyclosporin A: interference with the early activation of the membrane phospholipid metabolism in rabbit lymphocytes stimulated with concanavalin A, anti-rabbit immunoglobulin or the Ca2+ ionophore A 23187. Cell Immunol 93:239–249
Lakatos P, Stern PH (1991) Triiodothyronine stimulates the inositol phosphate second messenger pathway in bone. Calcif Tissue Int 48:53
Chenu C, Pfeilschifter J, Mundy GR, Roodman GD (1988) Transforming growth factor β inhibits formation of osteoclast-like cells in long-term human marrow cultures. Proc Natl Acad Sci USA 85:5683–5687
Soskolne WA, Schwartz Z, Goldstein M, Ornoy A (1990) The biphasic effect of triiodothyronine compared to bone-resorbing effect of PTH on bone modelling of mouse long bone in vitro. Bone 11:301–307
Pilbeam CC, Klein-Nulend J, Raisz LG (1989) Inhibition by 17β-estradiol of PTH-stimulated resorption and prostaglandin production in cultured neonatal mouse calvariae. Biochem Biophys Res Commun 163:1319–1324
Pilbeam CC, Raisz LG (1990) Effects of androgens on parathyroid hormone and interleukin-1-stimulated prostaglandin production in cultured neonatal mouse calvariate. J Bone Miner Res 5:1183–1188
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lakatos, P., Stern, P.H. Effects of cyclosporins and transforming growth factor β1 on thyroid hormone action in cultured fetal rat limb bones. Calcif Tissue Int 50, 123–128 (1992). https://doi.org/10.1007/BF00298788
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00298788